英語ページ

Publications 2008

  1. Horikawa, Y., Gu, J., Wu, X. (2008): Genetic susceptibility to bladder cancer with an emphasis on gene-gene and gene-environment interactions. Curr. Opin. Urol.,(2008) 18:493-198.
  2. Gu, J., Horikawa, Y., Chem, M., Dinney, CP., Wu, X. (2008) Benzo(a)pyrene diol epoxide-induced chromosome 9p21 aberrations are associated with increased risk of bladder cancer, Cancer Epidemiol. Biomarkers Prev., 17, 2445-2450.
  3. Horikawa, Y., Wood, C. G., Yang, H., Zhao, H., Ye, Y., Gu, J., Lin, J., Habuchi, T. and Wu, X. (2008) Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin. Cancer. Res., 14, 7956-7962.
  4. Horikawa, Y., Nadaoka, J., Saito, M., Kumazawa, T., Inoue, T., Yuasa, T., Tsuchiya, N., Nishiyama, H., Ogawa, O. and Habuchi, T. (2008) Clinical implications of the MDM2 SNP309 and p53 Arg72Pro polymorphisms in transitional cell carcinoma of the bladder. Oncol. Rep., 20, 49-55.
  5. Kagaya, H., Miura, M., Satoh, S., Inoue, K., Saito, M., Inoue, T., Habuchi, T. and Suzuki, T. (2008) No pharmacokinetic interactions between mycophenolic acid and tacrolimus in renal transplant recipients. J. Clin. Pharm. Ther., 33, 193-201.
  6. Kakehi, Y., Kamoto, T., Shiraishi, T., Ogawa, O., Suzukamo, Y., Fukuhara, S., Saito, Y., Tobisu, K., Kakizoe, T., Shibata, T., Fukuda, H., Akakura, K., Suzuki, H., Shinohara, N., Egawa, S., Irie, A., Sato, T., Maeda, O., Meguro, N., Sumiyoshi, Y., Suzuki, T., Shimizu, N., Arai, Y., Terai, A., Kato, T., Habuchi, T., Fujimoto, H. and Niwakawa, M. (2008) Prospective evaluation of selection criteria for active surveillance in Japanese patients with stage T1cN0M0 prostate cancer. Jpn. J. Clin. Oncol., 38, 122-128.
  7. Ma, Z., Tsuchiya, N., Yuasa, T., Inoue, T., Kumazawa, T., Narita, S., Horikawa, Y., Tsuruta, H., Obara, T., Saito, M., Satoh, S., Ogawa, O. and Habuchi, T. (2008) Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population. Int. J. Cancer., 123, 2574-2579.
  8. 8.Miura, M., Satoh, S., Niioka, T., Kagaya, H., Saito, M., Hayakari, M., Habuchi, T. and Suzuki, T. (2008) Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients. Ther. Drug Monit., 30, 52-59.
  9. Miura, M., Satoh, S., Inoue, K., Kagaya, H., Saito, M., Suzuki, T. and Habuchi, T. (2008) Influence of lansoprazole and rabeprazole on mycophenolic acid pharmacokinetics one year after renal transplantation. Ther. Drug Monit., 30, 46-51.
  10. 10.Miura, M., Satoh, S., Inoue, K., Kagaya, H., Saito, M., Inoue, T., Habuchi, T. and Suzuki, T. (2008) Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipients. Steroids, 73, 1052-1059.
  11. Miura, M., Kagaya, H., Satoh, S., Inoue, K., Saito, M., Habuchi, T., Suzuki, T. (2008) Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients. Ther. Drug Monit., Aug 7 (Epub ahead of print)
  12. 12.Nadaoka, J., Horikawa, Y., Saito, M., Kumazawa, T., Inoue, T., Narita, S., Yuasa, T., Satoh, S., Nishiyama, H., Ogawa, O., Tsuchiya, N. and Habuchi, T. (2008) Prognostic significance of HIF-1 alpha polymorphisms in transitional cell carcinoma of the bladder. Int. J. Cancer., 122, 1297-1302.
  13. 13.Narita, N., Yuasa, T., Tsuchiya, N., Kumazawa, T., Narita, S., Inoue, T., Ma, Z., Saito, M., Horikawa, Y., Satoh, S., Ogawa, O. and Habuchi, T. (2008) A genetic polymorphism of the osteoprotegerin gene is associated with an increased risk of advanced prostate cancer. BMC Cancer, 8, 224.
  14. 14.Narita, S., So, A., Ettinger, S., Hayashi, N., Muramaki, M., Fazli, L., Kim, Y., Gleave, M.E.(2008) GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer. Clin. Cancer Res. 14, 5769-77.
  15. 15.Narita, S., Tsuchiya, N., Saito, M., Inoue, T., Kumazawa, T., Yuasa, T., Nakamura, and Habuchi, T. (2008) Candidate genes involved in enhanced growth of human prostate cancer under high fat feeding identified by microarray analysis. Prostate, 68, 321-335.
  16. Saito, M., Yuasa, T., Satoh, S., Nanjo, H., Tsuchiya, N. and Habuchi, T. (2008) Developing multiple lung nodules in a renal transplant recipient with tuberous sclerosis who had undergone bilateral nephrectomy due to renal cell carcinomas. Int. J. Urol., 15, 257-258.
  17. Saito, M., Satoh, S., Kagaya, H., Tsuruta, H., Obara, T., Kumazawa, T., Inoue, T., Inoue, K., Miura, M., Yuasa, T., Komatsuda, A., Tsuchiya, N. and Habuchi, T. (2008) Thrombotic microangiopathy developing in early stage after renal transplantation with a high trough level of tacrolimus. Clin. Exp. Nephrol., 12, 312-315.
  18. Saito, M., Yuasa, T., Nanjo, H., Tsuchiya, N., Satoh, S. and Habuchi, T. (2008) A case of testicular angiomyolipoma. Int. J. Urol., 15, 185-187.
  19. 19.Saito, M., Satoh, S., Kagaya, H., Tsuruta, H., Obara, T., Kumazawa, T., Inoue, T., Inoue, K., Miura, M., Yuasa, T., Komatsuda, A., Tsuchiya, N. and Habuchi, T. (2008) Thrombotic microangiopathy developing in early stage after renal transplantation with a high trough level of tacrolimus. Clin. Exp. Nephrol., 12, 312-315.
  20. Satoh, S., Kagaya, H., Saito, M., Inoue, T., Miura, M., Inoue, K., Numakura, K., Tsuchiya, N., Tada, H., Suzuki, T. and Habuchi, T. (2008) Lack of tacrolimus circadian pharmacokinetics and CYP3A5 pharmacogenetics in the early and maintenance stages in Japanese renal transplant recipients. Br. J. Clin. Pharmacol., 66, 207-214.
  21. Terada, N., Tsuchiya, N., Ma, Z., Shimizu, Y., Kobayashi, T., Nakamura, E., Kamoto, T., Habuchi, T. and Ogawa, O. (2008) Association of genetic polymorphisms at 8q24 with the risk of prostate cancer in a Japanese population. Prostate, 68, 1689-1695.
  22. Tsuchiya, N., Inoue, T., Narita, S., Kumazawa, T., Saito, M., Obara, T., Tsuruta, H., Horikawa, Y., Yuasa, T., Satoh, S. and Habuchi, T. (2008) Drug related genetic polymorphisms affecting adverse reactions to methotrexate, vinblastine, doxorubicin and cisplatin in patients with urothelial cancer. J. Urol., 180, 2389-2395.
  23. 23.Wang, W., Yuasa, T., Tsuchiya, N., Maita, S., Kumazawa, T., Inoue, T., Saito, M., Ma, Z., Obara, T., Tsuruta, H., Satoh, S. and Habuchi, T. (2008) Bone mineral density in Japanese prostate cancer patients under androgen-deprivation therapy. Endocr. Relat. Cancer., 15, 943-952.
  24. Yuasa, T., Tsuchiya, N., Kumazawa, T., Inoue, T., Narita, S., Saito, M., Horikawa, Y., Satoh, S. and Habuchi, T. (2008) Characterization of prostate cancer detected at repeat biopsy. BMC Urol., 8, 14.
  25. 25.Yuasa, T., Sato, K., Ashihara, E., Takeuchi, M., Maita, S., Tsuchiya, N., Habuchi,
    T., Maekawa, T., and Kimura, S. (2008) Intravesical administration of gammadelta
    T cells successfully prevents the growth of bladder cancer in the murine model.
    Cancer Immunol. Immunother., 58, 493-502.
  26. 26.Zhu, Y., Horikawa, Y., Yang, H., Wood, C. G., Habuchi, T. and Wu, X. (2008) BPDE induced lymphocytic chromosome 3p deletions may predict renal cell carcinoma risk. J. Urol., 179, 2416-2421.

International Conference

    The 99th annual meeting of American Association for Cancer Research, April, San Diego

  1. Horikawa, Y., Yang, H., Ye, Y., Wood, CG., and Wu, X. (2008) Single nucleotide
    polymorphisms of miRNA machinery genes modify the risk of renal cell carcinoma

    2. The 102nd Annual Meeting of the American Urological Association, May, Orland

    1. Horikawa, Y., Zhu, Y., Yang, H., Wood, CG., and Wu, X. (2008) BPDE-induced chromosomal 3p deletions may predict renal cell carcinoma risk
    2. Nadaoka, J., Horikawa, Y., Saito, M., Kumazawa, T., Inoue, T., Narita, S., Yuasa, T., Satoh, S., Nishiyama, H., Ogawa, O., Tsuchiya, N., and Habuchi, T. (2008) Prognostic significance of HIF-1alpha polymorphisms in transitional cell carcinoma of the bladder
    3. Saito, M., Satoh, S., Inoue, T., Obara, T., Kumazawa, T., Tsuruta, H., Yuasa, T., Tsuchiya, N. and Habuchi, T. (2008) Implication of Compensatory Hyperfunction of Residual Kidney in Living Donors on Graft Function in Recipient
    4. Satoh, S., Numakura, K., Saito, M., Inoue, T., Inoue, K., Miura, M., Kagaya, H., Tsuruta, H., Obara, T., Kumazawa, T., Yuasa, T., Tsuchiya, N., Suzuki, T., and Habuchi, T. (2008) Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus and mycophenolate mofetil
    5. Saito, M., Satoh, S., Inoue, T., Tsuruta, H., Obara, T., Kumazawa, T., Yuasa, T., Tsuchiya, N. and Habuchi, T. (2008) CD20 Presenting B Cells Persistently Exist in Peripheral Lymph Nodes rather than Spleen after Low Dose Rituximab Administration in High Risk Renal Transplant Recipients
    6. 6.Wang, W., Yuasa, T., Tsuchiya, N., Kumazawa, T., Obara, T., Tsuruta, H., Saito, M., Inoue, T., Ma, Z., Satoh, S. and Habuchi, T. (2008) A mutant allele in a miR-181 binding-site of the Mel-18 gene is associated with a poor prognosis in prostate cancer
    7. Yuasa, T., Sato, K., Tsuchiya, N., Kimura, S., Ashihara, E., Takeuchi, M., Maekawa, T., and Habuchi, T. (2008) Intravesical administration of gammadelta T cells successfully prevents the growth of bladder cancer

    The Annunal Meeting of American Transplant Congress, May, Canada

    1. Satoh, S., Numakura, K., Saito, M., Inoue, T., Inoue, K., Miura, M., Kagaya, H., Tsuruta, H., Obara, T., Kumazawa, T., Yuasa, T., Tsuchiya, N., Suzuki, T., Habuchi, T. (2008) Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus and mycophenolate mofetil
    2. Satoh, S., Saito, M., Inoue, T., Kagaya, H., Miura, M., Inoue, K., Habuchi, T. (2008) Influence of CYP3A5 polymorphism on tacrolimus trough concentrations and acute rejection or chronic allogaft nephropathy in renal transplant recipients

    The 11th World Congress of Endoscopic Surgery, September, Yokohama

    1. Tsuruta, H., Kumazawa, T., Inoue, T., Narita, S., Horikawa, Y., Sato, S., Tsuchiya, N., and Habuchi, T. (2008) The Clinical Experience of Laparoscopic Adrenalectomy at the Akita University School of Medicine

    The Consensus Meeting on Therapeutic Drug Monitoring (TDM) of Mycophenolic Acids (MPA) by The Transplantation Society, November，Rome

    1. Satoh, S., and Miura, M. (2008) Invited Commentators for the Consensus Meeting on Therapeutic Drug Monitoring (TDM) of Mycophenolic Acids (MPA)

    Urological Research Society Meeting, October，Napa

    1. Tsuruta, H., Kishimoto, H., Sasaki, T., Horie, Y., Natsui, M., Shibata, Y., Hamada, K., Yajama, N., Kawahara, K., Sasaki, M., Tsuchiya, N., Enomoto, K., Tak, WM., Nakano, T., Habuchi, T. and Suzuki A. (2007) Hyperplasia and carcinomas in Pten-deficient mice and reduced PTEN protein in human bladder cancer patients.

    The 26th World Congress of Endourology, December, Shanghai

    1. Narita, S., Obara, T., Saito, M., Kumazawa, T., Horikawa, Y., Takeshi, Y., Tsuchiya, N., and Habuchi, T. (2008) Synchronous bilateral laparoscopic nephrectomy in patients with end-stage renal disease
    2. Tsuchiya, N., Inoue, T., Yuasa, T., Kanda, S., Kumazawa, T., Narita, S., Saito, M., Tsuruta, H., Satoh, S. and Habuchi, T. (2008) Simultaneous laparoscopic treatment for ureteropelvic junction obstruction accompanied by nephrolithiasis

    Asan-Akita Symposium, December, Seoul

      Narita, S. (2008) GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in urological cancer
© 2014 Department of Urology, Akita University Graduate School of Medicine. All Right Reserved.

メニューを開く